Filter Results:
(1,556)
Show Results For
- All HBS Web
(1,556)
- News (609)
- Research (788)
- Multimedia (53)
- Faculty Publications (550)
Show Results For
- All HBS Web
(1,556)
- News (609)
- Research (788)
- Multimedia (53)
- Faculty Publications (550)
- 12 Mar 2021
- News
It’s Time to Rethink Your Global Logistics
- August 2021
- Case
Yummy: Delivering Value to Venezuela
By: Ayelet Israeli, Jenyfeer Martinez Buitrago and Carla Larangeira
By June 2021, Yummy had become Venezuela’s first and largest food delivery app and last-mile logistics company. In Caracas, the nation’s capital, Yummy held a 55% market share, while operations in other cities had already started to take place, including in three of... View Details
Keywords: Internet and the Web; Health Pandemics; Business Startups; Growth and Development Strategy; Expansion
Israeli, Ayelet, Jenyfeer Martinez Buitrago, and Carla Larangeira. "Yummy: Delivering Value to Venezuela." Harvard Business School Case 522-034, August 2021.
- July 2021 (Revised February 2022)
- Case
Mary Kay Inc.: Enriching Women's Lives while Embracing Change
By: Elie Ofek, K. Shelette Stewart and Julia Kelley
In December 2020, Mary Kay Inc. Chief Marketing Officer Sheryl Adkins-Green considered several strategic dilemmas. Founded in 1963 by Mary Kay Ash, Mary Kay was a direct sales company whose Independent Beauty Consultants purchased its beauty and cosmetics products at... View Details
Keywords: Advertising Campaigns; Demographics; Marketing; Brands and Branding; Marketing Channels; Marketing Communications; Marketing Strategy; Product Marketing; Product Positioning; Social Marketing; Salesforce Management; Organizations; Mission and Purpose; Organizational Change and Adaptation; Innovation and Invention; Innovation Strategy; Competition; Competitive Strategy; Competitive Advantage; Beauty and Cosmetics Industry; North and Central America; United States; Europe; Asia; Texas
Ofek, Elie, K. Shelette Stewart, and Julia Kelley. "Mary Kay Inc.: Enriching Women's Lives while Embracing Change." Harvard Business School Case 522-004, July 2021. (Revised February 2022.)
Christopher T. Stanton
Christopher Stanton is Marvin Bower Associate Professor of Business Administration in the Entrepreneurial Management Unit. Professor Stanton's research streams focus on personnel economics, organizational economics, labor markets, and entrepreneurship. His MBA... View Details
- February 2024
- Teaching Note
AB InBev: Brewing Up Forecasts during COVID-19
By: Mark Egan and C. Fritz Foley
Teaching Note for HBS Case No. 224-020. In July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a... View Details
- September 2023 (Revised January 2024)
- Case
AB InBev: Brewing Up Forecasts during COVID-19
By: Mark Egan, C. Fritz Foley, Esel Cekin and Emilie Billaud
In July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a workforce of 160,000 in 2020, AB InBev... View Details
Keywords: Beer; Forecasting; COVID-19; Decision; Forecasting and Prediction; Analytics and Data Science; Crisis Management; Decisions; Financing and Loans; Investment Return; Resource Allocation; Distribution; Production; Business Processes; Strategic Planning; Health Pandemics; Digital Transformation; Markets; Food and Beverage Industry; Belgium; Europe; Latin America; North and Central America
Egan, Mark, C. Fritz Foley, Esel Cekin, and Emilie Billaud. "AB InBev: Brewing Up Forecasts during COVID-19." Harvard Business School Case 224-020, September 2023. (Revised January 2024.)
- Article
Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials
By: Caroline Marra, William J. Gordon and Ariel Dora Stern
Objectives: In an effort to mitigate COVID-19 related challenges for clinical research, the U.S. Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in the use of... View Details
Keywords: Connected Digital Products; Telehealth; Remote Monitoring; Health Testing and Trials; Research; Governing Rules, Regulations, and Reforms; Information Technology
Marra, Caroline, William J. Gordon, and Ariel Dora Stern. "Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials." BMJ Open 11, no. 6 (2021).
- January 19, 2021
- Article
How to Be a 'Glass-Shattering' Organization
By: Colleen Ammerman and Boris Groysberg
Advancing gender equality is certainly desirable, but may not seem vital during this turbulent time — yet that assumption couldn’t be further from the truth. In fact, losing sight of gender equity right now is likely to put you at a real disadvantage when the pandemic... View Details
Keywords: Gender Equity; Gender Inclusivity; Gender; Equality and Inequality; Organizational Change and Adaptation
Ammerman, Colleen, and Boris Groysberg. "How to Be a 'Glass-Shattering' Organization." Harvard Business Review Digital Articles (January 19, 2021).
Global Supply Chains in a Post-Pandemic World
The COVID-19 pandemic exposed the vulnerabilities in the production strategies and supply chains of firms everywhere. Coupled with a rise in economic nationalism, manufacturers everywhere are going to be under pressure to rethink their sourcing and logistics... View Details
- March 12, 2021
- Article
Is Your C-Suite Equipped to Lead a Digital Transformation?
By: J. Yo-Jud Cheng, Cassandra Frangos and Boris Groysberg
The pandemic has rapidly accelerated many companies’ digital efforts, but do they have the right executives in place to lead this sort of transformation? To answer this question, the authors analyzed more than 100 search specifications for C-suite positions in Fortune... View Details
Keywords: Management Teams; Information Technology; Transformation; Competency and Skills; Digital Transformation
Cheng, J. Yo-Jud, Cassandra Frangos, and Boris Groysberg. "Is Your C-Suite Equipped to Lead a Digital Transformation?" Harvard Business Review Digital Articles (March 12, 2021).
- Other Article
How to Make Remote Monitoring Tech Part of Everyday Health Care
By: Samantha F. Sanders, Ariel Dora Stern and William J. Gordon
Remote patient monitoring is a subset of telehealth that involves the collection, transmission, evaluation, and communication of patient health data from electronic devices. These devices include wearable sensors, implanted equipment, and handheld instruments. During... View Details
Keywords: Health Care and Treatment; Information Technology; Analytics and Data Science; Technology Adoption
Sanders, Samantha F., Ariel Dora Stern, and William J. Gordon. "How to Make Remote Monitoring Tech Part of Everyday Health Care." Harvard Business Review (website) (July 2, 2020).
- 12 Mar 2021
- News
Powering the Innovation Flywheel in the Digital Era
- 19 Jan 2021
- Cold Call Podcast
Engaging Community to Create Proactive, Equitable Public Safety
- 15 Jun 2021
- News
HBS Addresses Racial Equity
- Summer 2021
- Article
Predictable Country-level Bias in the Reporting of COVID-19 Deaths
By: Botir Kobilov, Ethan Rouen and George Serafeim
We examine whether a country’s management of the COVID-19 pandemic relate to the downward biasing of the number of reported deaths from COVID-19. Using deviations from historical averages of the total number of monthly deaths within a country, we find that the... View Details
Keywords: COVID-19; Deaths; Reporting; Incentives; Government Policy; Health Pandemics; Health Care and Treatment; Country; Crisis Management; Outcome or Result; Reports; Policy
Kobilov, Botir, Ethan Rouen, and George Serafeim. "Predictable Country-level Bias in the Reporting of COVID-19 Deaths." Journal of Government and Economics 2 (Summer 2021).
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details
Keywords: Ethics; Policy; Government and Politics; Health Pandemics; History; Rights; Media; Organizations; Business and Community Relations; Religion; Social Psychology; Identity; Prejudice and Bias; Social Issues; Public Opinion; Pharmaceutical Industry; Biotechnology Industry; Health Industry; Journalism and News Industry; Media and Broadcasting Industry; Public Administration Industry; United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- 30 Sep 2020
- Blog Post
Reflecting on my service
ventured into combat, protecting my fellow veterans as we transitioned back into a difficult world. So it was no surprise to me that as the COVID-19 pandemic unfolded, I found myself once again seeking to safeguard others, as the Deputy... View Details